Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Real-World Data & Evidence CollectionPost-Market Safety Registries
Research, Drug Development & Manufacturing

Medsafe & CARM Pharmacovigilance

Also known as: Medsafe, Centre for Adverse Reactions Monitoring, CARM

New Zealand pharmacovigilance infrastructure operated through Medsafe and CARM for adverse-reaction reporting, analysis, and signal monitoring. Public psychedelic-specific dashboards are limited; this profile is included as core safety infrastructure.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

1 country

Access Model

Open access

Last Verified

Apr 7, 2026

Methodology

Medsafe and CARM process spontaneous adverse-reaction reports and use them for pharmacovigilance signal detection; these data streams are directional and subject to under-reporting and reporting-bias constraints.

Safety monitoring registriesWeeklySafety surveillance data

Primary Dataset

View NZ ADR Reporting Statistics

Source Evidence

3 sources

Adverse reaction reporting in New Zealand - 2023

https://www.medsafe.govt.nz/safety/reports-and-promotion/ADRStatistics/2023.asp

Medsafe and CARM pharmacovigilance guidance

https://www.medsafe.govt.nz/Regulatory/requesting-adverse-reaction-information.asp

NZPhvC and CARM overview

https://nzphvc-carm.otago.ac.nz/

Quick Facts

Website
Visit